+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Autotransfusion Devices Market (by Type, Application, End User & Region): Insights and Forecast with Potential Impact of COVID-19 (2022-2027)

  • PDF Icon

    Report

  • 141 Pages
  • September 2023
  • Region: Global
  • Koncept Analytics
  • ID: 5879792
10% Free customization
10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.

Autotransfusion devices are used in medical procedures where the patient's own blood is reintroduced into the body following normal filtration. To put it another way, the patient turns into their own blood benefactor. It is easy to use and removes the infection before the blood is transfused back into the patient’s body.

These devices are commonly used in surgical procedures such as cardiac surgery, organ transplantation and other invasive procedures in which there is excessive blood loss. Factors that are contributing to the growth of the market are an increase in accidents, less availability of patients with rare blood group and high bleeding surgeries. The global autotransfusion devices market is foreseen to reach US$1.15 billion in 2023, growing at a CAGR of 5.78% during the forecasted period.

Segment Covered

  • By Type: The global autotransfusion devices market can be divided into two segments based on types: Product and Accessories. The products are further segmented into intraoperative, post-operative and dual mode. The intraoperative segment lead the autotransfusion product market, accounted for the highest share. Intraoperative Product is more thriving in the autotransfusion devices market because they usually helped in open heart surgeries, where blood loss is very high and being an important organ, the blood transfusion needs to be quick to restore the patient’s blood loss.
  • By Application: In terms of application, the report includes the segmentation into four categories namely Cardiac Surgeries, Orthopedic Surgeries, Trauma Procedures, and Others. Cardiac Surgeries held the maximum share in the autotransfusion devices market. The incidence of cardiac surgeries has increased in the past few years due to the increasing aging population and the rise in diabetic patients. Rise in smoking, high blood pressure, stress, etc. all lead to increase in the global cardiac surgeries autotransfusion devices market.
  • By End User: The report provides the bifurcation of the autotransfusion devices market into three segments based on end user: Hospital, Ambulatory Surgery Center and Speciality Clinics. The hospitals segment held the largest share of the global autotransfusion devices market. In hospitals, many patients walk in for diagnostics and a large number of patients are admitted for surgical procedures. As a result, hospitals currently hold a sizeable share in the market of autotransfusion devices, and this trend is anticipated to persist over the forecast period.

Geographic Coverage

According to this report, the global autotransfusion devices market is divided into four regions: North America, Europe, Asia Pacific, and rest of the world. The countries covered in North America region include US, Canada, and Mexico, while Europe includes Germany, France, UK, Italy, Spain, and Rest of Europe. Moreover, China, Japan, India, South Korea, Australia, and the Rest of the Asia Pacific are included in the Asia Pacific region. North America dominated the market with largest share of the global market. Factors such as the increasing prevalence of cancer in the US and Canada, rising number of patients suffering from cardiovascular, orthopedic diseases, an increase in the geriatric population, and surging cases of organs transplantation are the key factors driving the North America autotransfusion device market growth. Asia Pacific is anticipated to grow at the highest CAGR during the forecast period. Various government initiatives have helped in building necessary healthcare infrastructure, empowering healthcare providers and patients to opt for surgeries, hence boosting the demand for autotransfusion devices in the region.

Top Impacting Factors

Growth Drivers

  • Increasing Healthcare Spending
  • High Bleeding Surgeries
  • Increasing Accident Cases
  • Less Availability of Rare Blood Group

Challenges

  • High Cost Involved
  • Removal of Beneficial Components from Blood

Trends

  • Increasing Market Consolidation
  • Technological Developments

Driver: Increasing Accident Cases

The victims of automobile accidents, their families, and entire nations suffer severe economic losses. These expenses are brought on by the cost of medical care, the loss of wages for those who pass away or become disabled as a result of their injuries, and the cost of caring for loved ones who must take time off from their jobs or studies to tend to the injured. Usually accident cases need urgent medical attention because of heavy blood loss and sometimes the blood of some particular type is not available in the blood bank of hospital. So the patient can get quick blood via autotransfusion device as the there is no need to wait for blood donor. So, the autotransfusion devices is anticipated to be in demand as the number of accidents rises.

Challenge: Removal of Beneficial Components from Blood

Blood is a vital thing for human survival, any kind of blood transfusion is a risky procedure as maintaining blood composition after transfusing in patient’s blood circulation is quite challenging. Another big concern is that these machines cannot extract pollutants from blood without removing and discarding blood constituents other than red blood cells. This method may not be able to separate the undesirable stuff from the blood in some situations, and if operating mistakes or misuse occur, the machine may cause significant issues in the patient's body. Platelets and proteins such as clotting factors and albumin are among the helpful blood constituents that are eliminated. When blood loss is substantial, the removal of these components from blood might cause organ failure. As a result, the growth of autotransfusion devices may be slowed.

Trend: Increasing Market Consolidation

The consolidation phase is a stage in the industry life cycle where competitors in the industry start to merge. Companies would seek to consolidate to gain a larger portion of the overall market share and to take advantage of synergies. An increase in market size also provides an opportunity to expand the company's business line, which can lead to increased sales and profits as well. Therefore, the growing consolidation in the industry is expected to provide lucrative benefits and opportunities to the market leader in the coming years. Furthermore, several corporations used strategic actions such as acquisitions, partnerships, and others to gain market share. Medtronic, for example, bought AV Medical Technologies in October 2019. Getinge acquired Applikon Biotechnology in December 2019, which is the supplier of innovative bioreactor systems from the laboratory to the industrial scale. As a result, such improvements are anticipated to usher in new trends in the autotransfusion devices market in the future.

The COVID-19 Analysis

The COVID-19 was reported as an infectious disease with a high mortality rate, and which restricts blood donation activities and make it worse for rare blood group patients. Surgeries like renal surgery, cardiovascular surgery, cancer treatment surgery were cancelled or delayed in fear of COVID-19 infection. As a result, COVID-19 had a short-term detrimental impact on the autotransfusion devices market. After the vaccination schedule was established and the rate of transmission was reduced, healthcare systems were restored to normal. Health care sector are increasingly integrating artificial intelligence to solve the post COVID-19 challenges. Growing aesthetics awareness, increased surgical adoption, and increased affordability of advanced treatments are expected to drive the growth of the autotransfusion devices market in the post-COVID period.

Analysis of Key Players

The global autotransfusion device market is fragmented, with many players holding trivial market share. The key players of the globa autotransfusion device market are Becton, Dickinson & Company, Fresenius SE & Co.KGaA, Medtronic PLC, Zimmer Biomet Holdings Inc., Stryker Corporation, LivaNova PLC, Braile Biomedica, ProCell Surgical Inc., Haemonetic Corporation, SARSTEDT AG and Co.KG, Teleflex Incorporated, and Getinge (Atrium Medical Corporation).

Please note: 10% free customization equates to up to 3 hours of analyst time.

Table of Contents


1. Executive Summary
2. Introduction
2.1 Autotransfusion Devices: An Overview
2.2 Autotransfusion Devices Segmentation: An Overview
2.2.1 Autotransfusion Devices Segmentation

3. Global Market Analysis
3.1 Global Autotransfusion Devices Market: An Analysis
3.1.1 Global Autotransfusion Devices Market: An Overview
3.1.2 Global Autotransfusion Devices Market by Value
3.1.3 Global Autotransfusion Devices Market by Type (Product and Accessories)
3.1.4 Global Autotransfusion Devices Market by Application (Cardiac Surgeries, Orthopedic Surgeries, Trauma Procedures, and Others)
3.1.5 Global Autotransfusion Devices Market by End User (Hospital, Ambulatory Surgery Center, Specialty Clinics)
3.1.6 Global Autotransfusion Devices Market by Region (North America, Europe, Asia Pacific, and Rest of World)
3.2 Global Autotransfusion Devices Market: Type Analysis
3.2.1 Global Autotransfusion Devices Market by Type : An Overview
3.2.2 Global Autotransfusion Product Market by Value
3.2.3 Global Autotransfusion Product Market by Segments (Intraoperative, Postoperative and Dual Mode)
3.2.4 Global Autotransfusion Product Market Segments by Value
3.2.5 Global Autotransfusion Accessories Market by Value
3.3 Global Autotransfusion Devices Market: Application Analysis
3.3.1 Global Autotransfusion Devices Market by Application: An Overview
3.3.2 Global Cardiac Surgeries Autotransfusion Devices Market by Value
3.3.3 Global Orthopedic Surgeries Autotransfusion Devices Market by Value
3.3.4 Global Trauma Procedures Autotransfusion Devices Market by Value
3.3.5 Global Others Autotransfusion Devices Market by Value
3.4 Global Autotransfusion Devices Market: End User Analysis
3.4.1 Global Autotransfusion Devices Market by End User: An Overview
3.4.2 Global Hospital Autotransfusion Devices Market by Value
3.4.3 Global Ambulatory Surgery Centers Autotransfusion Devices Market by Value
3.4.4 Global Specialty Clinics Autotransfusion Devices Market by Value

4. Regional Market Analysis
4.1 North America Autotransfusion Devices Market: An Analysis
4.1.1 North America Autotransfusion Devices Market: An Overview
4.1.2 North America Autotransfusion Devices Market by Value
4.1.3 North America Autotransfusion Devices Market by Region (The US, Canada, and Mexico)
4.1.4 The US Autotransfusion Devices Market by Value
4.1.5 The US Autotransfusion Devices Market by Type (Accessories, Intraoperative, Postoperative and Dual Mode)
4.1.6 The US Autotransfusion Devices Market Type by Value
4.1.7 The US Autotransfusion Devices Market by Application (Cardiac Surgeries, Orthopedic Surgeries, Trauma Procedures, and Others)
4.1.8 The US Autotransfusion Devices Market Application by Value
4.1.9 Canada Autotransfusion Devices Market by Value
4.1.10 Mexico Autotransfusion Devices Market by Value
4.2 Europe Autotransfusion Devices Market: An Analysis
4.2.1 Europe Autotransfusion Devices Market: An Overview
4.2.2 Europe Autotransfusion Devices Market by Value
4.2.3 Europe Autotransfusion Devices Market by Region (Germany, France, UK, Italy, Spain, and Rest of the Europe)
4.2.4 Germany Autotransfusion Devices Market by Value
4.2.5 France Autotransfusion Devices Market by Value
4.2.6 UK Autotransfusion Devices Market by Value
4.2.7 Italy Autotransfusion Devices Market by Value
4.2.8 Spain Autotransfusion Devices Market by Value
4.2.9 Rest of the Europe Autotransfusion Devices Market by Value
4.3 Asia Pacific Autotransfusion Devices Market: An Analysis
4.3.1 Asia Pacific Autotransfusion Devices Market: An Overview
4.3.2 Asia Pacific Autotransfusion Devices Market by Value
4.3.3 Asia Pacific Autotransfusion Devices Market by Region (Japan, China, India, South Korea, Australia and Rest of Asia Pacific)
4.3.4 Japan Autotransfusion Devices Market by Value
4.3.5 China Autotransfusion Devices Market by Value
4.3.6 India Autotransfusion Devices Market by Value
4.3.7 South Korea Autotransfusion devices Market by Value
4.3.8 Australia Autotransfusion Devices Market by Value
4.3.9 Rest of Asia Pacific Autotransfusion Devices Market by Value
4.4 Rest of World Autotransfusion devices Market: An Analysis
4.4.1 Rest of World Autotransfusion Devices Market: An Overview
4.4.2 Rest of World Autotransfusion Devices Market by Value

5. Impact of COVID-19
5.1 Impact of COVID-19 On Autotransfusion Devices Market
5.2 Cancellation of Surgeries during COVID-19
5.3 Post COVID-19 Impact on Autotransfusion Device Market

6. Market Dynamics
6.1 Growth Driver
6.1.1 Increasing Healthcare Spending
6.1.2 High Bleeding Surgeries
6.1.3 Increasing Accident Cases
6.1.4 Less Availability of Rare Blood Group
6.1.5 Increasing Prevalence of Chronic Diseases
6.1.6 Rising Number of Transplants
6.1.7 Rapid Urbanization
6.2 Challenges
6.2.1 High Cost Involved
6.2.2 Removal of Beneficial Components from Blood
6.3 Market Trends
6.3.1 Increasing Market Consolidation
6.3.2 Technological Developments

7. Competitive Landscape
7.1 Global Autotransfusion Device Market Players by Product Comparison

8. Company Profiles
8.1 Medtronic PLC
8.1.1 Business Overview
8.1.2 Operating Segments
8.1.3 Business Strategy
8.2 Fresenius SE & Co. KGaA
8.2.1 Business Overview
8.2.2 Operating Segments
8.2.3 Business Strategy
8.3 Braile Biomedica
8.3.1 Business Overview
8.3.2 Business Strategy
8.4 Haemonetics Corporation
8.4.1 Business Overview
8.4.2 Operating Segments
8.4.3 Business Strategy
8.5 SARSTEDT AG & Co. KG
8.5.1 Business Overview
8.5.2 Business Strategy
8.6 Teleflex Incorporated
8.6.1 Business Overview
8.6.2 Operating Segments
8.6.3 Business Strategy
8.7 Becton, Dickinson & Company
8.7.1 Business Overview
8.7.2 Operating Segments
8.7.3 Business Strategy
8.8 LivaNova, PLC
8.8.1 Business Overview
8.8.2 Operating Segments
8.8.3 Business Strategy
8.9 ProCell Surgical Inc.
8.9.1 Business Overview
8.9.2 Business Strategy
8.10 Getinge (Atrium Medical Corporation)
8.10.1 Business Overview
8.10.2 Operating Segments
8.10.3 Business Strategy
8.11 Stryker Corporation
8.11.1 Business Overview
8.11.2 Operating Segment
8.11.3 Business Strategy
8.12 Zimmer Biomet Holdings, Inc.
8.12.1 Business Overview
8.12.2 Operating Segments
8.12.3 Business Strategy

List of Charts
  • Features of Autotransfusion Devices
  • Auto Transfusion Segmentation
  • Global Autotransfusion Devices Market by Value; 2017-2021 (US$ Billion)
  • Global Autotransfusion Devices Market by Value; 2022-2027 (US$ Billion)
  • Global Autotransfusion Devices Market by Type; 2021 (Percentage, %)
  • Global Autotransfusion Devices Market by Application; 2021 (Percentage, %)
  • Global Autotransfusion Devices Market by End User; 2021 (Percentage, %)
  • Global Autotransfusion Devices Market by Region; 2021 (Percentage, %)
  • Global Autotransfusion Product Market by Value; 2017-2021 (US$ Million)
  • Global Autotransfusion Product Market by Value; 2022-2027 (US$ Million)
  • Global Autotransfusion Product Market by Segments; 2021 (Percentage, %)
  • Global Autotransfusion Product Market Segments by Value; 2021-2027 (US$ Million)
  • Global Autotransfusion Accessories Market by Value; 2017-2021 (US$ Million)
  • Global Autotransfusion Accessories Market by Value; 2022-2027 (US$ Million)
  • Global Cardiac surgeries Autotransfusion Devices Market by Value; 2017-2021 (US$ Million)
  • Global Cardiac surgeries Autotransfusion Devices Market by Value; 2022-2027 (US$ Million
  • Global Orthopedic Surgeries Autotransfusion Devices Market by Value; 2017-2021 (US$ Million)
  • Global Orthopedic Surgeries Autotransfusion Devices Market by Value; 2022-2027 (US$ Million)
  • Global Trauma Procedures Autotransfusion Devices Market by Value; 2017-2021 (US$ Million)
  • Global Trauma Procedures Autotransfusion Devices Market by Value; 2022-2027 (US$ Million)
  • Global Others Autotransfusion Devices Market by Value; 2017-2021 (US$ Million)
  • Global Others Autotransfusion Devices Market by Value; 2022-2027 (US$ Million)
  • Global Hospital Autotransfusion Devices Market by Value; 2017-2021 (US$ Million)
  • Global Hospital Autotransfusion Devices Market by Value; 2022-2027 (US$ Million)
  • Global Ambulatory Surgeries Autotransfusion Devices Market by Value; 2017-2021 (US$ Million
  • Global Ambulatory Surgeries Autotransfusion devices Market by Value; 2022-2027 (US$ Million)
  • Global Specialty Clinics Autotransfusion Devices Market by Value; 2017-2021 (US$ Million)
  • Global Specialty Clinics Autotransfusion Devices Market by Value; 2022-2027 (US$ Million)
  • North America Autotransfusion Devices Market by Value; 2017-2021 (US$ Million)
  • North America Autotransfusion Devices Market by Value; 2022-2027 (US$ Million)
  • North America Autotransfusion Devices Market by Region; 2021 (Percentage, %)
  • The US Autotransfusion Devices Market by Value; 2021-2027 (US$ Million)
  • The US Autotransfusion Devices Market by Type; 2021 (Percentage, %)
  • The US Autotransfusion Devices Market Type by Value; 2021-2027 (US$ Million)
  • The US Autotransfusion Devices Market by Application; 2021 (Percentage, %)
  • The US Autotransfusion Devices Market Application by Value; 2021-2027 (US$ Million)
  • Canada Autotransfusion Devices Market by Value; 2021-2027 (US$ Million)
  • Mexico Autotransfusion Devices Market by Value; 2021-2027 (US$ Million)
  • Europe Autotransfusion Devices Market by Value; 2017-2021 (US$ Million)
  • Europe Autotransfusion Devices Market by Value; 2022-2027 (US$ Million)
  • Europe Autotransfusion Devices Market by Region; 2021 (Percentage, %)
  • Germany Autotransfusion Devices Market by Value; 2021-2027 (US$ Million)
  • France Autotransfusion Devices Market by Value; 2021-2027 (US$ Million)
  • UK Autotransfusion Devices Market by Value; 2021-2027 (US$ Million)
  • Italy Autotransfusion Devices Market by Value; 2021-2027 (US$ Million)
  • Spain Autotransfusion Devices Market by Value; 2021-2027 (US$ Million)
  • Rest of the Europe Autotransfusion Devices Market by Value; 2021-2027 (US$ Million)
  • Asia Pacific Autotransfusion Devices Market by Value; 2017-2021 (US$ Million)
  • Asia Pacific Autotransfusion Devices Market by Value; 2022-2027 (US$ Million)
  • Asia Pacific Autotransfusion Devices Market by Region; 2021 (Percentage, %)
  • Japan Autotransfusion Devices Market by Value; 2021-2027 (US$ Million)
  • China Autotransfusion Devices Market by Value; 2021-2027 (US$ Million)
  • India Autotransfusion Devices Market by Value; 2021-2027 (US$ Million)
  • South Korea Autotransfusion Devices Market by Value; 2021-2027 (US$ Million)
  • Australia Autotransfusion Devices Market by Value; 2021-2027 (US$ Million)
  • Rest of Asia Pacific Autotransfusion Devices Market by Value; 2021-2027 (US$ Million)
  • Rest of World Autotransfusion Devices Market by Value; 2017-2021 (US$ Million)
  • Rest of World Autotransfusion Devices Market by Value; 2022-2027 (US$ Million)
  • Global Total Cancelled Operations over a 12-week Period of Peak Disruption, by Specialty and Region; 2020 (Thousand)
  • Global Healthcare Spending Per Head by Region; 2018-2022 (US$)
  • Global Number of Transplants by Region; 2020-2021
  • Global Urban Population; 2015, 2020 & 2050 (Million)
  • Medtronic PLC Revenue by Segment; 2021 (Percentage, %)
  • Fresenius SE & Co. KGaA Sales by Segment; 2021 (Percentage, %)
  • Haemonetics Revenues by Segment; 2022 (Percentage, %)
  • Teleflex Incorporated Net Revenues by Segments; 2021 (Percentage, %)
  • Becton, Dickinson & Company Revenues by Segment; 2021 (Percentage, %)
  • LivaNova PLC Net Sales by Segment: 2021 (Percentage; %)
  • Getinge Net Sales by Segment; 2021 (Percentage; %)
  • Stryker Corporation Net Sales by Segment; 2021 (Percentage, %)
  • Zimmer Biomet Holdings, Inc. Sales by Segment; 2021 (Percentage, %)
List of Charts
  • Global Autotransfusion Device Market Players by Product Comparison

Companies Mentioned

  • Becton, Dickinson & Company
  • Braile Biomedica
  • Fresenius SE & Co. KGaA
  • Getinge (Atrium Medical Corporation)
  • Haemonetics Corporation
  • LivaNova, PLC
  • Medtronic PLC
  • ProCell Surgical Inc.
  • SARSTEDT AG & Co. KG
  • Stryker Corporation
  • Teleflex Incorporated
  • Zimmer Biomet Holdings, Inc.